DUBLIN--(BUSINESS WIRE)--Nov 8, 2019--

The "Antibacterial Drugs - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

The Antibacterial Drugs market worldwide is projected to grow by US$6 Billion, driven by a compounded growth of 1.8%

Enteral, one of the segments analyzed and sized in this study, displays the potential to grow at over 2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$31.3 Billion by the year 2025, Enteral will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 1.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$246.1 Million to the region's size and clout in the next 5 to 6 years. Over US$179.9 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Enteral will reach a market size of US$1.9 Billion by the close of the analysis period.

As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 2.8% over the next couple of years and add approximately US$1.6 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio.

Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:

  • Allergan PLC
  • AstraZeneca PLC
  • Bayer AG
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer, Inc.

Key Topics Covered:

1. Market Overview

2. Focus on Select Players

3. Market Trends & Drivers

4. Global Market Perspective

For more information about this report visit https://www.researchandmarkets.com/r/tnih3e

View source version on businesswire.com:https://www.businesswire.com/news/home/20191108005275/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: INFECTIOUS DISEASES PHARMACEUTICAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/08/2019 08:00 AM/DISC: 11/08/2019 08:01 AM

http://www.businesswire.com/news/home/20191108005275/en

Get daily news, sports, opinions, entertainment and more, delivered every morning.

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Copyright Business Wire 2019.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.